Nicotinamide relaxes vascular smooth muscle by inhibiting myosin light chain kinase-dependent signaling pathways: implications for anticancer efficacy.

David Hirst

Nicotinamide relaxes vascular smooth muscle by inhibiting myosin light chain kinase-dependent signaling pathways: implications for anticancer efficacy.

David Hirst

School of Pharmacy

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	483-489
Number of pages	7
Journal	Oncology Research - Anticancer drug design
Volume	14(10)
Issue number	10
Publication status	Published - 2004

ASJC Scopus subject areas

Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{b9ea89862a9640ffb21d7ae1e4a3fe53,

title = "Nicotinamide relaxes vascular smooth muscle by inhibiting myosin light chain kinase-dependent signaling pathways: implications for anticancer efficacy.",

author = "David Hirst",

year = "2004",

language = "English",

volume = "14(10)",

pages = "483--489",

journal = "Oncology Research - Anticancer drug design",

issn = "0965-0407",

publisher = "Cognizant Communication Corporation",

number = "10",

}

TY - JOUR

T1 - Nicotinamide relaxes vascular smooth muscle by inhibiting myosin light chain kinase-dependent signaling pathways: implications for anticancer efficacy.

AU - Hirst, David

PY - 2004

Y1 - 2004

UR - http://www.scopus.com/inward/record.url?scp=9244250304&partnerID=8YFLogxK

M3 - Article

C2 - 15559762

VL - 14(10)

SP - 483

EP - 489

JO - Oncology Research - Anticancer drug design

JF - Oncology Research - Anticancer drug design

SN - 0965-0407

IS - 10

ER -

Nicotinamide relaxes vascular smooth muscle by inhibiting myosin light chain kinase-dependent signaling pathways: implications for anticancer efficacy.

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this